44 results
Page 2 of 3
8-K
e1nzx1
24 Jan 22
Entry into a Material Definitive Agreement
8:00am
424B3
h62ld7a8m9
14 Jan 22
Prospectus supplement
5:18pm
424B5
u6rnlnf7ut8
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B5
4tf1snab ygz829a7e
1 Dec 21
Prospectus supplement for primary offering
5:10pm
DEF 14A
xvl18feu
22 Nov 21
Definitive proxy
4:37pm
424B5
r0bd90y48qye0f
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
ke17b5pwo2xh lfcbi
14 May 21
Quarterly report
4:31pm
10-K
p1fh16vzy5cridla6
31 Mar 21
Annual report
4:30pm
8-K
EX-10.1
5qwvgdrc
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
8-K/A
EX-99.1
hcur3h ehc
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-3.2
ygdjcdnvy7qsi6n p4
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
yzj p4xtc0z9ds4pq5
2 Nov 20
Prospectus supplement
12:00am